CXCL12/CXCR4轴在急性髓系白血病中的作用解析
本文综述CXCL12/CXCR4轴在急性髓系白血病(AML)发病中的核心作用,包括调控AML细胞黏附于骨髓保护龛、适应缺氧环境、迁移和生存。高CXCR4表达与较差的无复发生存和总生存相关。阻断该轴可提供「多靶点」治疗策略,现有小分子、肽类或单克隆抗体等CXCR4抑制剂已进入临床前和临床试验,但尚需进一步研究靶向多条信号通路的「多靶点」疗法。
要点
- CXCL12/CXCR4轴调控AML细胞黏附、缺氧适应、迁移和生存,是发病核心环节。
- 高CXCR4表达与AML患者较差的无复发生存和总生存相关。
- 阻断CXCL12/CXCR4轴可释放AML细胞出骨髓龛,增加对化疗敏感性。
核心结论
- CXCL12/CXCR4轴是AML发病的核心环节,阻断该轴具有治疗潜力。
- 需进一步研究靶向多条信号通路的「多靶点」疗法。
研究设计与样本
- 综述,检索范围未在摘要中报告。
主要发现
- CXCL12/CXCR4轴对AML细胞黏附于骨髓保护龛、适应缺氧环境、迁移和生存有根本性调控作用。
- 高CXCR4表达与较差的无复发生存和总生存相关。
- 骨髓中多种细胞表达CXCL12,促进恶性克隆的黏附和生存。
- 阻断CXCL12/CXCR4轴可防止生存信号并释放AML细胞入循环,使其更易被常规化疗药物破坏。
临床怎么用
- 阻断CXCL12/CXCR4轴可作为「多靶点」治疗策略,释放AML细胞出骨髓龛以增强化疗敏感性。
- 多种CXCR4抑制剂(小分子、肽类、单克隆抗体)已进入临床前和临床试验。
局限性
- 摘要未报告综述的检索范围及纳入研究的具体局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute myeloid leukaemia (AML) is the most common adult acute leukaemia with the lowest survival rate. It is characterised by a build-up of immature myeloid cells anchored in the protective niche of the bone marrow (BM) microenvironment. The CXCL12/CXCR4 axis is central to the pathogenesis of AML as it has fundamental control over AML cell adhesion into the protective BM niche, adaptation to the hypoxic environment, cellular migration and survival. High levels of CXCR4 expression are associated with poor relapse-free and overall survival. The CXCR4 ligand, CXCL12 (SDF-1), is expressed by multiple cells types in the BM, facilitating the adhesion and survival of the malignant clone. Blocking the CXCL12/CXCR4 axis is an attractive therapeutic strategy providing a 'multi-hit' therapy that both prevents essential survival signals and releases the AML cells from the BM into the circulation. Once out of the protective niche of the BM they would be more susceptible to destruction by conventional chemotherapeutic drugs. In this review, we disentangle the diverse roles of the CXCL12/CXCR4 axis in AML. We then describe multiple CXCR4 inhibitors, including small molecules, peptides, or monoclonal antibodies, which have been developed to date and their progress in pre-clinical and clinical trials. Finally, the review leads us to the conclusion that there is a need for further investigation into the development of a 'multi-hit' therapy that targets several signalling pathways related to AML cell adhesion and maintenance in the BM.
引用
- Ladikou EE, Chevassut T, Pepper CJ, et al. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia. Br J Haematol. 2020. PMID: 32135579. doi:10.1111/bjh.16456
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。